Advisors Asset Management Inc. lessened its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 19.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,731 shares of the technology company's stock after selling 6,564 shares during the quarter. Advisors Asset Management Inc.'s holdings in Amdocs were worth $2,361,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in the business. Nordea Investment Management AB grew its stake in Amdocs by 8.3% in the fourth quarter. Nordea Investment Management AB now owns 1,656,055 shares of the technology company's stock valued at $141,112,000 after purchasing an additional 127,426 shares in the last quarter. Mirabella Financial Services LLP boosted its holdings in shares of Amdocs by 204.2% in the 3rd quarter. Mirabella Financial Services LLP now owns 14,302 shares of the technology company's stock valued at $1,250,000 after buying an additional 9,600 shares during the last quarter. Pacer Advisors Inc. grew its stake in shares of Amdocs by 7.4% in the fourth quarter. Pacer Advisors Inc. now owns 1,815,675 shares of the technology company's stock valued at $154,587,000 after buying an additional 125,654 shares in the last quarter. Dudley & Shanley Inc. increased its holdings in Amdocs by 7.6% during the third quarter. Dudley & Shanley Inc. now owns 261,826 shares of the technology company's stock worth $22,905,000 after buying an additional 18,600 shares during the last quarter. Finally, Citigroup Inc. raised its position in Amdocs by 8.7% during the third quarter. Citigroup Inc. now owns 78,491 shares of the technology company's stock worth $6,866,000 after acquiring an additional 6,294 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.
Analyst Ratings Changes
Separately, StockNews.com downgraded shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, Amdocs presently has a consensus rating of "Moderate Buy" and a consensus target price of $101.20.
View Our Latest Stock Analysis on Amdocs
Amdocs Stock Performance
Amdocs stock traded up $1.55 during mid-day trading on Wednesday, hitting $91.97. 730,214 shares of the company's stock traded hands, compared to its average volume of 657,074. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The firm has a 50 day simple moving average of $87.46 and a two-hundred day simple moving average of $87.23. Amdocs Limited has a fifty-two week low of $74.41 and a fifty-two week high of $93.34. The stock has a market cap of $10.38 billion, a price-to-earnings ratio of 21.34, a P/E/G ratio of 1.47 and a beta of 0.68.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. On average, research analysts expect that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Monday, March 31st will be paid a dividend of $0.527 per share. The ex-dividend date of this dividend is Monday, March 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.29%. This is a positive change from Amdocs's previous quarterly dividend of $0.48. Amdocs's dividend payout ratio (DPR) is 48.72%.
About Amdocs
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.